Recruitment

Recruitment Status
Unknown status

Inclusion Criterias

Willingness by patient or parent to sign consent form;
Treatment with one or more chronic medications or regimes;
Diagnosis of CF clinically and by sweat test and/ or genetic testing and/ or nasal potential difference
...
Willingness by patient or parent to sign consent form;
Treatment with one or more chronic medications or regimes;
Diagnosis of CF clinically and by sweat test and/ or genetic testing and/ or nasal potential difference
Parents capable of complying with the program requirements including completing self-report questionnaires pre and post intervention completion.

Exclusion Criterias

Participation in other interventional studies within 2 weeks of recruitment or during the study period -
Having significant developmental delay or a mental health diagnosis of psychosis;
Transplant patients;
Participation in other interventional studies within 2 weeks of recruitment or during the study period -
Having significant developmental delay or a mental health diagnosis of psychosis;
Transplant patients;

Summary

Conditions
Cystic Fibrosis
Type
Interventional
Design
  • Allocation: Non-Randomized
  • Intervention Model: Single Group Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Supportive Care

Participation Requirements

Age
Between 8 years and 65 years
Gender
Both males and females

Description

The study will be an active interventional program for approximately six months in duration. All participants will initially undergo an initial assessment interview. Personnel trained and certified in mindfulness-based stress reduction (MBSR) will run mindfulness-based groups in 6-8 weekly 1 1/2 hou...

The study will be an active interventional program for approximately six months in duration. All participants will initially undergo an initial assessment interview. Personnel trained and certified in mindfulness-based stress reduction (MBSR) will run mindfulness-based groups in 6-8 weekly 1 1/2 hour sessions (the staff group will comprise of 6 sessions and the parents' and patients' groups will be 8 sessions long). Participants will learn and engage in various formal and informal meditation practices during experiential learning of skills, including concentration, mindfulness of thoughts, emotions, feelings and bodily sensations, decentering, and letting go. Each group will include both practical exercises and a psycho-educational component. Daily homework, an essential aspect of the course, will include meditation practices together with exercises designed to integrate application of awareness skills into daily life. On day 0, participants will complete a battery of questionnaires as well as tests of the physical status of CF disease. This battery will be repeated at 8 weeks, and again at 6 months.

Inclusion Criterias

Willingness by patient or parent to sign consent form;
Treatment with one or more chronic medications or regimes;
Diagnosis of CF clinically and by sweat test and/ or genetic testing and/ or nasal potential difference
...
Willingness by patient or parent to sign consent form;
Treatment with one or more chronic medications or regimes;
Diagnosis of CF clinically and by sweat test and/ or genetic testing and/ or nasal potential difference
Parents capable of complying with the program requirements including completing self-report questionnaires pre and post intervention completion.

Exclusion Criterias

Participation in other interventional studies within 2 weeks of recruitment or during the study period -
Having significant developmental delay or a mental health diagnosis of psychosis;
Transplant patients;
Participation in other interventional studies within 2 weeks of recruitment or during the study period -
Having significant developmental delay or a mental health diagnosis of psychosis;
Transplant patients;

Locations

Petah Tikva, 49202
Petah Tikva, 49202

Tracking Information

NCT #
NCT02131857
Collaborators
Not Provided
Investigators
  • Principal Investigator: Hannah Blau, MBBS Rabin Medical Center
  • Hannah Blau, MBBS Rabin Medical Center